Yükleniyor... / Loading...
This observational study aims to evaluate the clinical and functional features of children with inherited non-Duchenne myopathies (a group of inherited muscle disorders causing muscle weakness). Patients aged 2-18 with a diagnosis confirmed by clinical, laboratory, and genetic testing can take part. It is a study without an assigned phase and is still enrolling participants.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * • Age between 2 and 18 years * Confirmed diagnosis of non-DMD based on clinical features, laboratory investigations, and genetic testing. * Patients and their parents agree to participate in the study. Exclusion Criteria: * • Children with a confirmed diagnosis of DMD * Children with incomplete medical records or unavailable clinical data. * Children with endocrinal ,nutritional critical care and inflammatory myopathies. * Other neuromuscular disorders that affect AHC or nerves as SMA, congenital myasthenia Gravis and neuropathic. * Other acquired neuromuscular disorders as Guillain Barre syndrome and toxic myopathy. * Patients and their parents refuse to participate in the study.